Cargando…

Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive Histology

INTRODUCTION: Little is known about the anticipated disease course for individuals who present with renal-limited antineutrophil cytoplasmic antibody (ANCA)−associated vasculitis but who lack inflammation on a kidney biopsy. The impact of immunosuppression on renal and overall survival is unknown. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Novick, Tessa K., Chen, Min, Scott, Jennifer, Cortazar, Frank B., Ayoub, Isabelle, Little, Mark A., Hruskova, Zdenka, Salama, Alan D., Pagnoux, Christian, Geetha, Duvuru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976815/ https://www.ncbi.nlm.nih.gov/pubmed/29854975 http://dx.doi.org/10.1016/j.ekir.2018.01.012

Ejemplares similares

Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Geetha, Duvuru, et al.
Publicado: (2018)

Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients
por: Aqeel, Faten, et al.
Publicado: (2022)

Characteristics and Outcomes of COVID-19 in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Kant, Sam, et al.
Publicado: (2020)

Subcutaneous Immunoglobulin for Antibody Deficiency in Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis
por: Kant, Sam, et al.
Publicado: (2019)

Long-term Clinical Course of Antineutrophil Cytoplasmic Antibody-associated Vasculitis Patients off Maintenance Therapy
por: Gapud, Eric J, et al.
Publicado: (2018)

Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis
por: Ghosh, Jyotsna, et al.
Publicado: (2021)

Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
por: Huizenga, Noah, et al.
Publicado: (2019)

SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
por: Floyd, Lauren, et al.
Publicado: (2021)

Repeat Kidney Biopsies in Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis: Clinical and Histologic Progression
por: Aqeel, Faten, et al.
Publicado: (2023)

Relevance of Combined Clinicopathologic Phenotype and Antineutrophil Cytoplasmic Autoantibody Serotype in the Diagnosis of Antineutrophil Cytoplasmic Autoantibody Vasculitis
por: Alba, Marco A., et al.
Publicado: (2022)

Comparison of Radiological and Histological Findings of Lung Parenchyma in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Park, Hee-Jin, et al.
Publicado: (2019)

Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody–Associated Vasculitis: Systematic Review and Meta‐Analysis
por: Bénard, Valérie, et al.
Publicado: (2021)

Myeloperoxidase Antineutrophil Cytoplasmic Antibody-Associated Renal-Limited Vasculitis in a Young Adult Woman
por: Otaka, Yukihiro, et al.
Publicado: (2022)

Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use
por: Shikha, Deep, et al.
Publicado: (2015)

Stress and Disease Onset in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Golemati, Christina V., et al.
Publicado: (2017)

The role of mycophenolate in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis
por: Koukoulaki, Maria, et al.
Publicado: (2019)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis
por: Li, Weiran, et al.
Publicado: (2021)

Isolated Antineutrophil Cytoplasmic Antibody-Associated Coronary Vasculitis and Valvulitis
por: Kim, Yoon Kook, et al.
Publicado: (2021)

Polypharmacy in US Medicare beneficiaries with antineutrophil cytoplasmic antibody vasculitis
por: Cao, Binxin, et al.
Publicado: (2023)

Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Merkel, Peter A., et al.
Publicado: (2020)

Management of antineutrophil cytoplasmic antibody–associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations
por: Casal Moura, Marta, et al.
Publicado: (2023)

Neutrophilic Dermatoses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A French Multicenter Study of 17 Cases and Literature Review
por: de Boysson, Hubert, et al.
Publicado: (2016)

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
por: Merkel, Peter A., et al.
Publicado: (2017)

Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Ohashi, Keiji, et al.
Publicado: (2017)

Propylthiouracil-induced Otitis Media with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Tanaka, Rika, et al.
Publicado: (2018)

Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary–renal syndrome
por: Aeddula, Narothama Reddy, et al.
Publicado: (2018)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review
por: Choi, Chan-Bum, et al.
Publicado: (2019)

Antineutrophil Cytoplasmic Antibody Vasculitis Causing Skull Base Inflammation and Aortitis
por: Maramattom, Boby Varkey, et al.
Publicado: (2018)

Azathioprine Intolerance in Japanese Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Morishita, Michiko, et al.
Publicado: (2017)

Hydralazine-Induced Dual Antineutrophil Cytoplasmic Antibody Positive Vasculitis and Nephritis
por: Padala, Sandeep A, et al.
Publicado: (2020)

Association of COVID‐19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis
por: Felzer, Jamie R., et al.
Publicado: (2021)

Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis
por: Casal Moura, Marta, et al.
Publicado: (2021)

Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis
por: Tran, John Chuan Nguyen, et al.
Publicado: (2022)

Suspicion Is Key: Diagnosing Elusive Cytoplasmic Antineutrophil Cytoplasmic Antibody (c-ANCA)-Positive Vasculitis
por: Crowe, Timothy P, et al.
Publicado: (2022)

Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis
por: Kant, Sam, et al.
Publicado: (2021)

Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Shah, Shivani, et al.
Publicado: (2017)

Urine and Plasma Complement Ba Levels During Disease Flares in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
por: Almaani, Salem, et al.
Publicado: (2023)

Pulmonary Fibrosis in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis: A Series of 49 Patients and Review of the Literature
por: Comarmond, Cloé, et al.
Publicado: (2014)

Serum interleukin-16 significantly correlates with the Vasculitis Damage Index in antineutrophil cytoplasmic antibody-associated vasculitis
por: Yoon, Taejun, et al.
Publicado: (2020)

Acute Respiratory Failure as Primary Manifestation of Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis
por: Sourla, Evdokia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k7a0tp27h8jr4npmfbep99ncbb